183 related articles for article (PubMed ID: 10830423)
1. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.
Aylward EH; Codori AM; Rosenblatt A; Sherr M; Brandt J; Stine OC; Barta PE; Pearlson GD; Ross CA
Mov Disord; 2000 May; 15(3):552-60. PubMed ID: 10830423
[TBL] [Abstract][Full Text] [Related]
2. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
[TBL] [Abstract][Full Text] [Related]
3. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
[TBL] [Abstract][Full Text] [Related]
5. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.
Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883
[TBL] [Abstract][Full Text] [Related]
6. Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation?
Mandelli ML; Savoiardo M; Minati L; Mariotti C; Aquino D; Erbetta A; Genitrini S; Di Donato S; Bruzzone MG; Grisoli M
AJNR Am J Neuroradiol; 2010 Apr; 31(4):706-10. PubMed ID: 19942704
[TBL] [Abstract][Full Text] [Related]
7. Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study.
Aylward EH; Rosenblatt A; Field K; Yallapragada V; Kieburtz K; McDermott M; Raymond LA; Almqvist EW; Hayden M; Ross CA
Brain Res Bull; 2003 Dec; 62(2):137-41. PubMed ID: 14638387
[TBL] [Abstract][Full Text] [Related]
8. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease.
Sritharan A; Egan GF; Johnston L; Horne M; Bradshaw JL; Bohanna I; Asadi H; Cunnington R; Churchyard AJ; Chua P; Farrow M; Georgiou-Karistianis N
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):257-62. PubMed ID: 19237387
[TBL] [Abstract][Full Text] [Related]
10. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
11. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
Wardlaw JM; Sellar RJ; Abernethy LJ
Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
[TBL] [Abstract][Full Text] [Related]
12. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical correlates of caudate atrophy in Huntington's disease.
Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
[TBL] [Abstract][Full Text] [Related]
14. Onset and rate of striatal atrophy in preclinical Huntington disease.
Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
[TBL] [Abstract][Full Text] [Related]
15. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
Furukawa F; Ishikawa K; Yokota T; Sanjo N
Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
[TBL] [Abstract][Full Text] [Related]
16. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.
Hobbs NZ; Barnes J; Frost C; Henley SM; Wild EJ; Macdonald K; Barker RA; Scahill RI; Fox NC; Tabrizi SJ
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1036-41. PubMed ID: 20150305
[TBL] [Abstract][Full Text] [Related]
17. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.
Turner LM; Jakabek D; Wilkes FA; Croft RJ; Churchyard A; Walterfang M; Velakoulis D; Looi JC; Georgiou-Karistianis N; Apthorp D
Brain Behav; 2016 Dec; 6(12):e00511. PubMed ID: 28031992
[TBL] [Abstract][Full Text] [Related]
18. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
[TBL] [Abstract][Full Text] [Related]
19. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
[TBL] [Abstract][Full Text] [Related]
20. Abnormal MRI signal in the rigid form of Huntington's disease.
Savoiardo M; Strada L; Oliva D; Girotti F; D'Incerti L
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):888-91. PubMed ID: 1836015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
